What is he best known for?
The fields of study he is best known for:
- Surgery
- Cancer
- Internal medicine
His primary areas of investigation include Surgery, Lung cancer, Respiratory disease, Survival rate and Carcinoma.
Chemotherapy is the focus of his Surgery research.
His studies in Lung cancer integrate themes in fields like Randomized controlled trial, Radiation therapy and In situ hybridization.
His Respiratory disease research integrates issues from Stage, Angiogenesis and Vascular permeability.
Joe B. Putnam has included themes like Magnetic resonance imaging and Chest pain in his Survival rate study.
His Carcinoma research focuses on subjects like Oncology, which are linked to Tumor biology.
His most cited work include:
- A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung Cancer (944 citations)
- Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. (629 citations)
- Morbidity and Mortality of Major Pulmonary Resections in Patients With Early-Stage Lung Cancer: Initial Results of the Randomized, Prospective ACOSOG Z0030 Trial (495 citations)
What are the main themes of his work throughout his whole career to date?
Surgery, Lung cancer, Internal medicine, Oncology and Radiology are his primary areas of study.
His studies deal with areas such as Respiratory disease and Carcinoma as well as Surgery.
Joe B. Putnam usually deals with Respiratory disease and limits it to topics linked to Metastasis and Sarcoma.
His Lung cancer study which covers Cancer that intersects with Biomarker.
The Radiology study combines topics in areas such as Differential diagnosis and Resection.
His studies examine the connections between Pneumonectomy and genetics, as well as such issues in Cardiothoracic surgery, with regards to Thoracotomy.
He most often published in these fields:
- Surgery (62.65%)
- Lung cancer (43.78%)
- Internal medicine (27.31%)
What were the highlights of his more recent work (between 2009-2021)?
- Lung cancer (43.78%)
- Surgery (62.65%)
- Internal medicine (27.31%)
In recent papers he was focusing on the following fields of study:
Joe B. Putnam mainly focuses on Lung cancer, Surgery, Internal medicine, Oncology and Radiology.
His work carried out in the field of Lung cancer brings together such families of science as Cancer, Proportional hazards model, Stage, Prospective cohort study and Receiver operating characteristic.
His research on Surgery often connects related topics like Pneumonectomy.
His study on Carcinoma, Phases of clinical research, Clinical trial and Lymphadenectomy is often connected to Panitumumab as part of broader study in Internal medicine.
In his research, Docetaxel is intimately related to Radiation therapy, which falls under the overarching field of Oncology.
His Radiology research is multidisciplinary, incorporating perspectives in Differential diagnosis and Confidence interval.
Between 2009 and 2021, his most popular works were:
- Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non–small cell carcinoma: Results of the American College of Surgery Oncology Group Z0030 Trial (397 citations)
- Video-assisted thoracic surgery versus open lobectomy for lung cancer: a secondary analysis of data from the American College of Surgeons Oncology Group Z0030 randomized clinical trial. (244 citations)
- Automated Symptom Alerts Reduce Postoperative Symptom Severity After Cancer Surgery: A Randomized Controlled Clinical Trial (178 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Surgery
- Internal medicine
His primary scientific interests are in Lung cancer, Surgery, Internal medicine, Cardiothoracic surgery and Oncology.
His research in Lung cancer intersects with topics in Immunohistochemistry, Cancer, Radiology, Prospective cohort study and Receiver operating characteristic.
His biological study spans a wide range of topics, including Pneumonectomy, Lymph node and Pulmonary function testing.
His Cardiothoracic surgery study deals with Thoracotomy intersecting with Randomized controlled trial, Lung cancer surgery and Propensity score matching.
His research integrates issues of Survival rate, Carcinoma, Lymphadenectomy and Lymph in his study of Oncology.
His Survival rate research integrates issues from Carboplatin, Clinical endpoint, Chemotherapy and Hazard ratio.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
